Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00707057 · ClinicalTrials.gov registry record · Phase 3
Ibuprofen Extended-Release Dental Pain Study
A Phase 3 study of Pain and Postoperative Pain, sponsored by SCOLR Pharma.
- Completed
- Registry status
- Phase 3
- Development phase
- 256
- Enrollment target
- 1
- Study location
NCT00707057: Completed Phase 3 study of Pain and Postoperative Pain, sponsored by SCOLR Pharma.
NCT00707057 is a Phase 3 study of Pain and Postoperative Pain that has completed, run by SCOLR Pharma. The registered enrollment target is 256 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (16% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00707057, a Phase 3 study of Pain and Postoperative Pain, has completed, sponsored by SCOLR Pharma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 256 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the efficacy and safety of multiple doses of Ibuprofen 600 mg Extended-Release Tablets in a study of dental pain following extraction of third molar teeth.
Primary Outcome
Analgesic efficacy for the 8-12 hour measurement interval after dose 1 using Sum of Pain Intensity Differences (SPID). An 11-point Pain Intensity Numerical Rating Scale (PI-NRS) was used to record pain intensity at baseline and 8, 9, 10, 11, 12 hours after dose 1. The scale went from 0 (no pain) to 10 (Worst possible pain). The outcome measure is based a mean of the sum of each of the five time points evaluated. The total time scale ranges from 0 to 50. Subjects were asked to select the number
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Ibuprofen 600 mg Extended-Release Tablets
Study Locations (1)
Utah
- Jean Brown Research - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2008-06 |
| Est. Completion | 2008-10 |
| Phase | Phase 3 |
What the finished NCT00707057 record still lists
NCT00707057 is an interventional study that assigns participants to a tested intervention. The registered 256 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (16% lower).
The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00707057 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT00707057 about?
NCT00707057 is a clinical study titled "Ibuprofen Extended-Release Dental Pain Study". The purpose of this study is to evaluate the efficacy and safety of multiple doses of Ibuprofen 600 mg Extended-Release Tablets in a study of dental pain following extraction of third molar teeth.
What is the current status of trial NCT00707057?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 256 participants. The study started on 2008-06. Estimated completion is 2008-10.
What conditions does trial NCT00707057 study?
This clinical trial studies the following conditions: Pain, Postoperative Pain, Third Molar Extraction.
What interventions are being tested in trial NCT00707057?
The interventions under investigation include: Placebo (DRUG), Ibuprofen 600 mg Extended-Release Tablets (DRUG).
Who is sponsoring clinical trial NCT00707057?
This trial is sponsored by SCOLR Pharma, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00707057 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00707057's enrollment target sits among peer trials
256 68th of 374 higher than 307 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Suzetrigine in Total Hip Arthroplasty
RECRUITING · Phase 3
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
RECRUITING · Phase 3
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02464696 · 256 participants · NA
Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
- NCT03793062 · 256 participants
Genetic and Epigenetic Basis of Chronic Wounds
- NCT04322318 · 256 participants · Phase 2
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- NCT04468360 · 256 participants · Phase 2
Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia